Enablex Novartis Pharmaceuticals Corporation - Treatment for Overactive Bladder

Enablex is a potent muscarinic receptor antagonist indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency.

Posted: December 2004

Enablex (darifenacin) FDA Approval History

View comments

Hide
(web4)